SMS Lifesciences India

quarterly
yearly
ParticularsJun '21Sep '21Dec '21Mar '22Jun '22
Revenue76.0086.7591.0695.6682.28
Expenses69.8679.8385.2190.7976.38
EBITDA6.146.925.854.875.90
EBIT4.014.233.242.293.31
Profit Before Tax5.0313.554.399.764.57
Net Profit3.6310.252.339.073.01
Financial Ratios
Operating Profit Margin8.08%7.98%6.42%5.10%7.17%
Net Profit Margin4.78%11.82%2.56%9.48%3.66%
Earning Per Share (Diluted)12.0014.457.7030.009.95
Dividends Per ShareNANANA1.50NA
ⓒ 2016-2022 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 3.3.8
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI